PDF: Update on Drugs & Devices: January-February 2026

PDF Download: Update on Calcipotriene and betamethasone dipropionate cream, 0.005%/0.064% (Wynzora®), Roflumilast foam 0.3% (Zoryve®), Roflumilast cream 0.05% (Zoryve®), and Lidocaine topical system 10% (Bondlido®)
Read online:
https://www.skintherapyletter.com/drug-updates/jan-feb-2026/